Skip to main content
. 2016 Jan 18;3(5):465–471. doi: 10.1002/mdc3.12309

Figure 1.

Figure 1

Consortium on Risk for Early Onset Parkinson's Disease (CORE‐PD) enrollment and frequency of mutation carriers in the deep brain stimulation (DBS) and non‐DBS groups. GBA, glucocerebrosidase; LRRK2, leucine‐rich repeat kinase 2 (all individuals with LRRK2 had the glycine‐to‐serine mutation at codon 2019 [G2019S]); PRKN, parkin. Asterisks indicate values that reflect the total number of unique subjects with mutations.